About Us Services Careers FAQ Contact Us 0
Home Biotechnology DNA Sequencing Market Size & Trends Analysis Report | 2033

DNA Sequencing Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation DNA Sequencing), By Applications (Oncology, Clinical investigation, Agrigenomics & forensics, HLA typing/immune system monitoring, Drug development, Others), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI56520DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global DNA Sequencing Market Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.S.
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.K.
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. China
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. UAE
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. Brazil
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. DNA Sequencing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific, Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Agilent Technology
    3. Illumina, Inc.
    4. QIAGEN
    5. F. Hoffmann-La Roche Ltd.
    6. Macrogen, Inc.
    7. PerkinElmer Genomics
    8. PacBio
    9. BGI
    10. Bio-Rad Laboratories, Inc.
    11. Myriad Genetics
    12. PierianDx
    13. Partek Incorporated
    14. Eurofins Scientific
    15. Oxford Nanopore Technologies
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Access


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.